| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.012 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0062 | 1 |